BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

882 related articles for article (PubMed ID: 24841269)

  • 1. Screening of an FDA-approved compound library identifies four small-molecule inhibitors of Middle East respiratory syndrome coronavirus replication in cell culture.
    de Wilde AH; Jochmans D; Posthuma CC; Zevenhoven-Dobbe JC; van Nieuwkoop S; Bestebroer TM; van den Hoogen BG; Neyts J; Snijder EJ
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4875-84. PubMed ID: 24841269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Abelson Kinase Inhibitors Are Potent Inhibitors of Severe Acute Respiratory Syndrome Coronavirus and Middle East Respiratory Syndrome Coronavirus Fusion.
    Coleman CM; Sisk JM; Mingo RM; Nelson EA; White JM; Frieman MB
    J Virol; 2016 Oct; 90(19):8924-33. PubMed ID: 27466418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Repurposing of clinically developed drugs for treatment of Middle East respiratory syndrome coronavirus infection.
    Dyall J; Coleman CM; Hart BJ; Venkataraman T; Holbrook MR; Kindrachuk J; Johnson RF; Olinger GG; Jahrling PB; Laidlaw M; Johansen LM; Lear-Rooney CM; Glass PJ; Hensley LE; Frieman MB
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4885-93. PubMed ID: 24841273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternative screening approaches for discovery of Middle East respiratory syndrome coronavirus inhibitors.
    LaFemina RL
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4251-2. PubMed ID: 24867994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro virucidal activity of Echinaforce®, an Echinacea purpurea preparation, against coronaviruses, including common cold coronavirus 229E and SARS-CoV-2.
    Signer J; Jonsdottir HR; Albrich WC; Strasser M; Züst R; Ryter S; Ackermann-Gäumann R; Lenz N; Siegrist D; Suter A; Schoop R; Engler OB
    Virol J; 2020 Sep; 17(1):136. PubMed ID: 32907596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel Frameshifting Inhibitor Having Antiviral Activity against Zoonotic Coronaviruses.
    Ahn DG; Yoon GY; Lee S; Ku KB; Kim C; Kim KD; Kwon YC; Kim GW; Kim BT; Kim SJ
    Viruses; 2021 Aug; 13(8):. PubMed ID: 34452503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Broad Anti-coronavirus Activity of Food and Drug Administration-Approved Drugs against SARS-CoV-2
    Weston S; Coleman CM; Haupt R; Logue J; Matthews K; Li Y; Reyes HM; Weiss SR; Frieman MB
    J Virol; 2020 Oct; 94(21):. PubMed ID: 32817221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alisporivir inhibits MERS- and SARS-coronavirus replication in cell culture, but not SARS-coronavirus infection in a mouse model.
    de Wilde AH; Falzarano D; Zevenhoven-Dobbe JC; Beugeling C; Fett C; Martellaro C; Posthuma CC; Feldmann H; Perlman S; Snijder EJ
    Virus Res; 2017 Jan; 228():7-13. PubMed ID: 27840112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 3C-like protease inhibitors block coronavirus replication in vitro and improve survival in MERS-CoV-infected mice.
    Rathnayake AD; Zheng J; Kim Y; Perera KD; Mackin S; Meyerholz DK; Kashipathy MM; Battaile KP; Lovell S; Perlman S; Groutas WC; Chang KO
    Sci Transl Med; 2020 Aug; 12(557):. PubMed ID: 32747425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of SSYA10-001 as a replication inhibitor of severe acute respiratory syndrome, mouse hepatitis, and Middle East respiratory syndrome coronaviruses.
    Adedeji AO; Singh K; Kassim A; Coleman CM; Elliott R; Weiss SR; Frieman MB; Sarafianos SG
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4894-8. PubMed ID: 24841268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resveratrol Inhibits HCoV-229E and SARS-CoV-2 Coronavirus Replication In Vitro.
    Pasquereau S; Nehme Z; Haidar Ahmad S; Daouad F; Van Assche J; Wallet C; Schwartz C; Rohr O; Morot-Bizot S; Herbein G
    Viruses; 2021 Feb; 13(2):. PubMed ID: 33672333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small-Molecule Antiviral β-d-
    Agostini ML; Pruijssers AJ; Chappell JD; Gribble J; Lu X; Andres EL; Bluemling GR; Lockwood MA; Sheahan TP; Sims AC; Natchus MG; Saindane M; Kolykhalov AA; Painter GR; Baric RS; Denison MR
    J Virol; 2019 Dec; 93(24):. PubMed ID: 31578288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural-based virtual screening and in vitro assays for small molecules inhibiting the feline coronavirus 3CL protease as a surrogate platform for coronaviruses.
    Theerawatanasirikul S; Kuo CJ; Phecharat N; Chootip J; Lekcharoensuk C; Lekcharoensuk P
    Antiviral Res; 2020 Oct; 182():104927. PubMed ID: 32910955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-Throughput Screening and Identification of Potent Broad-Spectrum Inhibitors of Coronaviruses.
    Shen L; Niu J; Wang C; Huang B; Wang W; Zhu N; Deng Y; Wang H; Ye F; Cen S; Tan W
    J Virol; 2019 Jun; 93(12):. PubMed ID: 30918074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Broad-spectrum coronavirus antiviral drug discovery.
    Totura AL; Bavari S
    Expert Opin Drug Discov; 2019 Apr; 14(4):397-412. PubMed ID: 30849247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiviral Activity of Umifenovir In Vitro against a Broad Spectrum of Coronaviruses, Including the Novel SARS-CoV-2 Virus.
    Leneva I; Kartashova N; Poromov A; Gracheva A; Korchevaya E; Glubokova E; Borisova O; Shtro A; Loginova S; Shchukina V; Khamitov R; Faizuloev E
    Viruses; 2021 Aug; 13(8):. PubMed ID: 34452529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human coronavirus dependency on host heat shock protein 90 reveals an antiviral target.
    Li C; Chu H; Liu X; Chiu MC; Zhao X; Wang D; Wei Y; Hou Y; Shuai H; Cai J; Chan JF; Zhou J; Yuen KY
    Emerg Microbes Infect; 2020 Dec; 9(1):2663-2672. PubMed ID: 33179566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Saracatinib Inhibits Middle East Respiratory Syndrome-Coronavirus Replication In Vitro.
    Shin JS; Jung E; Kim M; Baric RS; Go YY
    Viruses; 2018 May; 10(6):. PubMed ID: 29795047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and evaluation of a series of acyclic fleximer nucleoside analogues with anti-coronavirus activity.
    Peters HL; Jochmans D; de Wilde AH; Posthuma CC; Snijder EJ; Neyts J; Seley-Radtke KL
    Bioorg Med Chem Lett; 2015 Aug; 25(15):2923-6. PubMed ID: 26048809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening of FDA-Approved Drugs Using a MERS-CoV Clinical Isolate from South Korea Identifies Potential Therapeutic Options for COVID-19.
    Ko M; Chang SY; Byun SY; Ianevski A; Choi I; Pham Hung d'Alexandry d'Orengiani AL; Ravlo E; Wang W; Bjørås M; Kainov DE; Shum D; Min JY; Windisch MP
    Viruses; 2021 Apr; 13(4):. PubMed ID: 33918958
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.